U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (AK-HER2)Cat. No. WA1600Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (AK-HER2)Cat. No. WA1600
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (ADCT-502)Cat. No. WA1599
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (ABGN-110)Cat. No. WA1598
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (1F2)Cat. No. WA1597
U-Blot® Research Grade Anti-Human CD337/NCR3 Antibody (BGA-1833)Cat. No. WA1596
U-Blot® Research Grade Anti-Human CD335/NCR1/NKp46 Antibody (A26-BhlgG1)Cat. No. WA1595
U-Blot® Research Grade Anti-Human CD335/NCR1/NKp46 (BL-9020)Cat. No. WA1594
U-Blot® Research Grade Anti-Human CD334/FGFR4 (U3-1784)Cat. No. WA1593
U-Blot® Research Grade Anti-Human CD333/FGFR3 (LY3076226)Cat. No. WA1592
U-Blot® Research Grade Anti-Human CD332/FGFR2 (HuGAL-FR21)Cat. No. WA1591
U-Blot® Research Grade Anti-Human CD332/FGFR2 (GP369)Cat. No. WA1590
U-Blot® Research Grade Anti-Human CD332/FGFR2 (DS-1123)Cat. No. WA1589